Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Survival Tree01:19

Survival Tree

418
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
418
Survival Curves01:18

Survival Curves

696
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
696
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

765
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
765
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

583
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
583
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

611
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
611
Censoring Survival Data01:09

Censoring Survival Data

539
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
539

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduction of Cerebrospinal Fluid Leaks in Idiopathic Intracranial Hypertension with Glucagon-like Peptide-1 Receptor Agonist Use.

Journal of neurological surgery. Part B, Skull base·2026
Same author

Can ChatGPT Replace Human Clinical Coders? A Comparative Study in Otology Billing.

The Annals of otology, rhinology, and laryngology·2026
Same author

Assessment of Surgical Salvage Outcomes for Exposed Cranial Neuromodulating Devices.

The Annals of otology, rhinology, and laryngology·2026
Same author

Presynaptic Ca<sub>V</sub>2.1 calcium dependent facilitation is essential for faithful auditory information transfer.

bioRxiv : the preprint server for biology·2026
Same author

Audiometric Outcomes and Longitudinal Trends of Sequential Cochlear Implantation in Adults with Bilateral Deafness: A 20-Year Single-Center Study.

Audiology & neuro-otology·2026
Same author

Understanding barriers to pediatric hydrocephalus management: an international survey.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2026

Related Experiment Video

Updated: Jan 27, 2026

Extracting the Cochlea from a Human Temporal Bone: A Cadaveric Protocol
06:42

Extracting the Cochlea from a Human Temporal Bone: A Cadaveric Protocol

Published on: August 18, 2023

1.9K

Temporal bone carcinoma: Treatment patterns and survival.

Kristen L Seligman1, Daniel Q Sun1, Patrick P Ten Eyck2

  • 1Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa.

The Laryngoscope
|March 16, 2019
PubMed
Summary

Temporal bone carcinoma survival is improved with basal cell carcinoma histology and lateral temporal bone resection. Dural invasion does not preclude successful surgical outcomes in select patients.

Keywords:
Temporal bone carcinomabasal cell carcinomasquamous cell carcinomatemporal bone resection

More Related Videos

High-Speed Human Temporal Bone Sectioning for the Assessment of COVID-19-Associated Middle Ear Pathology
03:42

High-Speed Human Temporal Bone Sectioning for the Assessment of COVID-19-Associated Middle Ear Pathology

Published on: May 18, 2022

2.6K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.7K

Related Experiment Videos

Last Updated: Jan 27, 2026

Extracting the Cochlea from a Human Temporal Bone: A Cadaveric Protocol
06:42

Extracting the Cochlea from a Human Temporal Bone: A Cadaveric Protocol

Published on: August 18, 2023

1.9K
High-Speed Human Temporal Bone Sectioning for the Assessment of COVID-19-Associated Middle Ear Pathology
03:42

High-Speed Human Temporal Bone Sectioning for the Assessment of COVID-19-Associated Middle Ear Pathology

Published on: May 18, 2022

2.6K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.7K

Area of Science:

  • Oncology
  • Otorhinolaryngology
  • Surgical Pathology

Background:

  • Carcinomas of the temporal bone are rare, leading to limited data on optimal treatment, staging, and survival.
  • Understanding prognostic factors is crucial for managing locally advanced disease, including skull base and dural invasion.

Purpose of the Study:

  • To evaluate clinical characteristics and survival rates of patients with temporal bone carcinoma treated with resection.
  • To identify factors influencing outcomes, particularly in cases with locally advanced disease.

Main Methods:

  • Retrospective chart review of patients with primary temporal bone carcinomas from 2003-2015.
  • Staging using the modified Pittsburgh system; survival analysis via Kaplan-Meier and logistic regression.

Main Results:

  • Sixty-seven patients included; 64% squamous cell carcinoma, 36% basal cell carcinoma (BCC).
  • Favorable 5-year survival linked to BCC histology, lateral temporal bone resection, lack of immunocompromise, and absence of perineural/lymphovascular invasion.
  • Dural invasion was present in some patients who survived over 5 years.

Conclusions:

  • Prognostic factors for better survival include BCC histology, lack of immunocompromise, absence of perineural/lymphovascular invasion, and suitability for lateral temporal bone resection.
  • Dural invasion is not an absolute contraindication for surgical resection in temporal bone carcinoma.